Salivary Gland Toxicity of PSMA-Targeted Radioligand Therapy with 177 Lu-PSMA and Combined 225 Ac- and 177 Lu-Labeled PSMA Ligands (TANDEM-PRLT) in Advanced Prostate Cancer: A Single-Center Systematic Investigation.
Thomas LangbeinHarshad R KulkarniChristiane SchuchardtDirk MuellerGerd Fabian VolkRichard P BaumPublished in: Diagnostics (Basel, Switzerland) (2022)
Lu-PSMA-I&T/-617 causes only minor SG toxicity, while one cycle of Tandem-PRLT results in a significant SG impairment. This standardized protocol may help to objectify and quantify SG dysfunction.